Insider Trading Alert - AMRI, AMRK And WIFI Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 13, 2015, 91 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $377.89 to $223,379,993.30.

Highlighted Stocks Traded by Insiders:

Albany Molecular Research (AMRI) - FREE Research Report

D Ambra Constance M, who is 10% Owner at Albany Molecular Research, sold 20,000 shares at $19.11 on May 13, 2015. Following this transaction, the 10% Owner owned 2.4 million shares meaning that the stake was reduced by 0.81% with the 20,000-share transaction.

D Ambra Thomas E Phd, who is Chairman, Board of Directors at Albany Molecular Research, sold 20,000 shares at $19.11 on May 13, 2015. Following this transaction, the Chairman, Board of Directors owned 2.6 million shares meaning that the stake was reduced by 0.77% with the 20,000-share transaction.

The shares most recently traded at $19.38, up $0.27, or 1.39% since the insider transaction. Historical insider transactions for Albany Molecular Research go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 40,000
  • 12-Week # shares bought: 30,000
  • 12-Week # shares sold: 84,662
  • 24-Week # shares bought: 30,000
  • 24-Week # shares sold: 206,285

The average volume for Albany Molecular Research has been 457,800 shares per day over the past 30 days. Albany Molecular Research has a market cap of $633.9 million and is part of the health care sector and drugs industry. Shares are up 17.57% year-to-date as of the close of trading on Wednesday.

Albany Molecular Research, Inc., a contract research and manufacturing company, provides integrated drug discovery, development, and manufacturing services primarily in the United States, Europe, and Asia. Currently, there are 2 analysts who rate Albany Molecular Research a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AMRI - FREE

TheStreet Quant Ratings rates Albany Molecular Research as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. Get the full Albany Molecular Research Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

A-Mark Precious Metals (AMRK) - FREE Research Report

Meltzer Carol, who is General Counsel at A-Mark Precious Metals, sold 2,000 shares at $10.83 on May 13, 2015. Following this transaction, the General Counsel owned 45,401 shares meaning that the stake was reduced by 4.22% with the 2,000-share transaction.

The shares most recently traded at $11.00, up $0.17, or 1.51% since the insider transaction. Historical insider transactions for A-Mark Precious Metals go as follows:

  • 4-Week # shares sold: 3,300
  • 12-Week # shares sold: 10,100
  • 24-Week # shares sold: 13,400

The average volume for A-Mark Precious Metals has been 11,700 shares per day over the past 30 days. A-Mark Precious Metals has a market cap of $75.3 million and is part of the financial sector and financial services industry. Shares are up 8.43% year-to-date as of the close of trading on Wednesday.

A-Mark Precious Metals, Inc. operates as a precious metals trading company in North America, Europe, the Asia Pacific, Africa, Australia, and South America. It offers gold, silver, platinum, and palladium in the form of bars, plates, powder, wafers, grain, ingots, and coins. The company has a P/E ratio of 12.6.

Exclusive Offer: Get the latest Stock Analysis on AMRK - FREE

TheStreet Quant Ratings rates A-Mark Precious Metals as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, unimpressive growth in net income, generally high debt management risk, poor profit margins and generally disappointing historical performance in the stock itself. Get the full A-Mark Precious Metals Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Boingo Wireless (WIFI) - FREE Research Report

Boesenberg Charles, who is Director at Boingo Wireless, sold 10,000 shares at $8.97 on May 13, 2015. Following this transaction, the Director owned 25,674 shares meaning that the stake was reduced by 28.03% with the 10,000-share transaction.

The shares most recently traded at $8.82, down $0.15, or 1.7% since the insider transaction. Historical insider transactions for Boingo Wireless go as follows:

  • 4-Week # shares sold: 2,500
  • 12-Week # shares sold: 5,000
  • 24-Week # shares sold: 690,412

The average volume for Boingo Wireless has been 323,400 shares per day over the past 30 days. Boingo Wireless has a market cap of $326.7 million and is part of the technology sector and telecommunications industry. Shares are up 16.3% year-to-date as of the close of trading on Wednesday.

Boingo Wireless, Inc., together with its subsidiaries, provides high-speed, high-bandwidth wireless Internet service to smartphones, tablet computers, laptops, and other wireless-enabled devices. Currently, there are 4 analysts who rate Boingo Wireless a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WIFI - FREE

TheStreet Quant Ratings rates Boingo Wireless as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and disappointing return on equity. Get the full Boingo Wireless Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

EY's Greene Sees More Med Tech, CRO Deals Ahead

EY's Greene Sees More Med Tech, CRO Deals Ahead

Biotech Movers: Albany Molecular Shares Soar on Sale to PE Firms

Biotech Movers: Albany Molecular Shares Soar on Sale to PE Firms

Albany Molecular Research (AMRI) Is Weak On High Volume Today

Albany Molecular Research (AMRI) Is Weak On High Volume Today

Insider Trading Alert - MGRC, GUID And AMRI Traded By Insiders

Insider Trading Alert - MGRC, GUID And AMRI Traded By Insiders

Insider Trading Alert - NTGR, SCOR And AMRI Traded By Insiders

Insider Trading Alert - NTGR, SCOR And AMRI Traded By Insiders